Table: Phoenixbio - 6-MTH group results

PhoenixBio

14/11/2024 06:35

Nov 14 (Reuters)- 
             Phoenixbio Co., Ltd. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   6 months ended      6 months ended        Year to  
                  Sep 30, 2024        Sep 30, 2023      Mar 31, 2025  
                     LATEST             YEAR-AGO           LATEST     
                     RESULTS             RESULTS          FORECAST    
  Sales              788 mln             881 mln            1.52      
                   (-10.6 pct)         (-22.3 pct)       (-11.3 pct)  
  Operating        loss 98 mln         loss 5 mln       loss 253 mln  
  Recurring       loss 123 mln           45 mln         loss 277 mln  
                                       (-88.6 pct)                    
  Net             loss 124 mln           27 mln         loss 281 mln  
                                       (-92.3 pct)                    
  EPS            loss 30.89 yen         7.53 yen       loss 69.54 yen 
  EPS Diluted                           5.22 yen                      
  Ann Div                                  NIL               NIL      
  -Q2 div              NIL                 NIL                        
  -Q4 div                                  NIL               NIL      
  
  NOTE - Phoenixbio Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=6190.T